Literature DB >> 15047088

The medical practice of patient autonomy and cancer treatment refusals: a patients' and physicians' perspective.

Titia van Kleffens1, Berna van Baarsen, Evert van Leeuwen.   

Abstract

The idea that patients should take up an autonomous position in the decision-making process is generally appreciated. However, what patient autonomy means in the case of patients who refuse a recommended oncological treatment has not been investigated. This study aims to clarify how the concept of patient autonomy can be applied to patients who refuse a recommended oncological treatment. Focus questions are: (1) what is meant by patient autonomy, i.e. how is this autonomy conceptualised and (2) which factors influence patient autonomy. A qualitative study design with in-depth interviews was performed. The study sample included 30 cancer patients and 16 physicians. All patients had refused a recommended oncological treatment. Patient autonomy was revealed to be a comprehensive concept with elaborations on 'making decisions' and 'defining life choices' as sub-concepts of patient autonomy. In contrast to what is generally believed, decisions of patients to refuse an oncological treatment do not so much rely on the medical information about disease and treatment options, but are rather inspired by patients' own experiences or those of close others. The medical information and the role of the physician do, however, influence patients' experiences of being free and/or of having a choice. The results show that the extent of pressure physicians will exert to persuade the patient to be treated as recommended depends on the medical distinction between a curative and a non-curative treatment goal. It seems that there exists a shift in respecting patient autonomy, which depends on factors like treatment goal. Discussing the respect shift may serve to clarify underlying thoughts and principles in the decision-making process for both physicians and patients.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Year:  2004        PMID: 15047088     DOI: 10.1016/j.socscimed.2003.08.027

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  12 in total

1.  Factors influencing treatment selection and survival in advanced lung cancer.

Authors:  S Tabchi; E Kassouf; M Florescu; M Tehfe; N Blais
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

2.  Physicians' evaluations of patients' decisions to refuse oncological treatment.

Authors:  T van Kleffens; E van Leeuwen
Journal:  J Med Ethics       Date:  2005-03       Impact factor: 2.903

3.  Elucidating patient-perceived role in "decision-making" among African Americans receiving lung cancer care through a county safety-net system.

Authors:  Simon Craddock Lee; Emily G Marks; Joanne M Sanders; Deborah J Wiebe
Journal:  J Cancer Surviv       Date:  2015-06-16       Impact factor: 4.442

4.  Characteristics of older newly diagnosed cancer patients refusing cancer treatments.

Authors:  Martine T E Puts; Johanne Monette; Veronique Girre; Christina Wolfson; Michèle Monette; Gerald Batist; Howard Bergman
Journal:  Support Care Cancer       Date:  2010-04-25       Impact factor: 3.603

5.  Knowledge and practices of obtaining informed consent for medical procedures among specialist physicians: questionnaire study in 6 Croatian hospitals.

Authors:  Marko Jukic; Slavica Kvolik; Goran Kardum; Slavica Kozina; Ana Tomic Juraga
Journal:  Croat Med J       Date:  2009-12       Impact factor: 1.351

6.  What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders.

Authors:  Jada G Hamilton; Sarah E Lillie; Dana L Alden; Laura Scherer; Megan Oser; Christine Rini; Miho Tanaka; John Baleix; Mikki Brewster; Simon Craddock Lee; Mary K Goldstein; Robert M Jacobson; Ronald E Myers; Brian J Zikmund-Fisher; Erika A Waters
Journal:  J Behav Med       Date:  2016-08-26

7.  Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey.

Authors:  Richard L Nahin; Danita Byrd-Clark; Barbara J Stussman; Nilesh Kalyanaraman
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

8.  Health behaviors and risk factors in those who use complementary and alternative medicine.

Authors:  Richard L Nahin; James M Dahlhamer; Beth L Taylor; Patricia M Barnes; Barbara J Stussman; Catherine M Simile; Marc R Blackman; Margaret A Chesney; Morgan Jackson; Heather Miller; Kim K McFann
Journal:  BMC Public Health       Date:  2007-08-27       Impact factor: 3.295

9.  Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.

Authors:  Hsiu-Ling Huang; Pei-Tseng Kung; Chang-Fang Chiu; Yueh-Hsin Wang; Wen-Chen Tsai
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program.

Authors:  Chun-Yi Liu; William Tzu-Liang Chen; Pei-Tseng Kung; Chang-Fang Chiu; Yueh-Hsin Wang; Shwn-Huey Shieh; Wen-Chen Tsai
Journal:  BMC Cancer       Date:  2014-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.